Email updates

Keep up to date with the latest news and content from BMC Medicine and BioMed Central.

Journal App

google play app store

Download references

Open Access

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

Clifford J Bailey*, Jorge L Gross, Delphine Hennicken, Nayyar Iqbal, Traci A Mansfield and James F List

BMC Medicine 2013, 11:43  doi:10.1186/1741-7015-11-43

Include


Format